These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 22776312)

  • 1. Exosomes are endogenous nanoparticles that can deliver biological information between cells.
    Sun D; Zhuang X; Zhang S; Deng ZB; Grizzle W; Miller D; Zhang HG
    Adv Drug Deliv Rev; 2013 Mar; 65(3):342-7. PubMed ID: 22776312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes as nano-theranostic delivery platforms for gene therapy.
    Tan A; Rajadas J; Seifalian AM
    Adv Drug Deliv Rev; 2013 Mar; 65(3):357-67. PubMed ID: 22820532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
    Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
    Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes as nucleic acid nanocarriers.
    van den Boorn JG; Dassler J; Coch C; Schlee M; Hartmann G
    Adv Drug Deliv Rev; 2013 Mar; 65(3):331-5. PubMed ID: 22750807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles and microparticles for skin drug delivery.
    Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS
    Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery.
    Yeo RW; Lai RC; Zhang B; Tan SS; Yin Y; Teh BJ; Lim SK
    Adv Drug Deliv Rev; 2013 Mar; 65(3):336-41. PubMed ID: 22780955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Gao K; Jiang X
    Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.
    Schädlich A; Caysa H; Mueller T; Tenambergen F; Rose C; Göpferich A; Kuntsche J; Mäder K
    ACS Nano; 2011 Nov; 5(11):8710-20. PubMed ID: 21970766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes: the ideal nanovectors for biodelivery.
    Fais S; Logozzi M; Lugini L; Federici C; Azzarito T; Zarovni N; Chiesi A
    Biol Chem; 2013 Jan; 394(1):1-15. PubMed ID: 23241589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
    Kreuter J; Hekmatara T; Dreis S; Vogel T; Gelperina S; Langer K
    J Control Release; 2007 Mar; 118(1):54-8. PubMed ID: 17250920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery with topically applied nanoparticles: science fiction or reality.
    Lademann J; Richter H; Meinke MC; Lange-Asschenfeldt B; Antoniou C; Mak WC; Renneberg R; Sterry W; Patzelt A
    Skin Pharmacol Physiol; 2013; 26(4-6):227-33. PubMed ID: 23921109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of polymeric nanoparticles in the targeting drugs carriers].
    Li S; Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):495-7. PubMed ID: 15250165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
    Kuo YC; Lee CL
    Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.